Hydrocarbon toxicity: A review

Clinical Toxicology

Volumn 52, Issue 5, 2014, Pages 479-489

  Tormoehlen, L M ^a   Tekulve, K J ^a   Nanagas K A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Aspiration pneumonitis; Delirium; Inhalant abuse; Sudden sniffing death; Toluene

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; HALOGENATED HYDROCARBON; HALOPERIDOL; HYDROCARBON; TOLUENE;

ASPIRATION PNEUMONIA; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DEPRESSION; COGNITIVE DEFECT; COMA; DEMENTIA; DERMATITIS; DIFFERENTIAL DIAGNOSIS; HEART ARRHYTHMIA; HUMAN; HYPERCHLOREMIA; HYPOKALEMIA; INHALANT ABUSE; INTOXICATION; KIDNEY TUBULE ACIDOSIS; LEUKOENCEPHALOPATHY; METABOLIC ACIDOSIS; NONHUMAN; PSYCHOSIS; REVIEW; SNIFFING; SUBSTANCE ABUSE; WEAKNESS;

ASPIRATION PNEUMONITIS; DELIRIUM; INHALANT ABUSE; SUDDEN SNIFFING DEATH; TOLUENE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANIMALS; CHILD; HUMANS; HYDROCARBONS; INHALANT ABUSE; PNEUMONIA, ASPIRATION; SOLVENTS; SUBSTANCE-RELATED DISORDERS;

EID: 84902288721     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.923904     Document Type: Review

References (150)

1. Hamilton W. Death from drinking coal oil. J Am Med Assn 1926;87:214-215.
2. Caplan JP, Pope AE, Boric CA, Benford DA. Air conditioner refrigerant inhalation: a habit with chilling consequences. Psychosomatics 2012;53:273-276.
3. Bass M. Sudden sniffing death. J Am Med Assoc 1970;212:2075-2079.
4. Burns CB, Currie B. The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers. Aust N Z J Med 1995;25:197-203.
5. LoVecchio F, Sawyers B, Tholel D, Beuler M, Winchell J, Curry S. Outcomes following abuse of methanolcontaining carburetor cleaners. Hum Exp Toxicol 2004;23:473-475.
6. Givens M, Kalbfleisch K, Bryson S. Comparison of methanol exposure routes reported to Texas poison control centers. West J Emerg Med 2008;9:150.
7. Mowry JB, Spyker DA, Cantilena LRJ, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers ' National Poison Data System (NPDS): 30th Annual Report. J Toxicol Clin Toxicol 2013;51:949-1229.
8. Cobaugh DJ, Seger DL, Krenzelok EP. Hydrocarbon toxicity: an analysis of AAPCC TESS data. Przegl Lek 2007;64:194-196.
9. Kurtzman TL, Otsuka KN, Wahl RA. Inhalant abuse by adolescents. J Adolesc Health 2001;28:170-180.
10. Williams JF, Storck M. Inhalant abuse. Pediatrics 2007;119:1009-1017.
11. Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 1998;286:334-340.
12. Bowen SE, Batis JC, Paez-Martinez N, Cruz SL. The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 2006;28:636-647.
13. Cruz SL, Balster RL, Woodward JJ. Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br JPharmacol 2000;131:1303-1308.
14. Bale AS, Tu Y, Carpenter-Hyland EP, Chandler LJ, Woodward JJ. Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience 2005;130:197-206.
15. MacIver MB. Abused inhalants enhance GABA-mediated synaptic inhibition. Neuropsychopharmacol 2009;34:2296-2304.
16. Riegel AC, French ED. An electrophysiological analysis of rat ventral tegmental dopamine neuronal activity during acute toluene exposure. Pharmacol Toxicol 1999;85:37-43.
17. Riegel AC, Zapata A, Shippenberg TS, French ED. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacol 2007;32:1558-1569.
18. Riegel AC, Ali SF, Torinese S, French ED. Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat. Ann N Y Acad Sci 2004;1025:543-551.
19. Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 2011;6:18-31.
20. Lubman DI, Yucel M, Lawrence AJ. Inhalant abuse among adolescents: neurobiological considerations. Br JPharmacol 2008;154:316-26.
21. Beckstead MJ, Weiner JL, Eger EI II, Gong DH, Mihic SJ. Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 2000;57:1199-1205.
22. Zhvania MG, Chilachava LR, Japaridze NJ, Gelazonia LK, Lordkipanidze TG. Immediate and persisting effect of toluene chronic exposure on hippocampal cell loss in adolescent and adult rats. Brain Res Bull 2012;87:187-192.
23. Mattia C, Ali S, Bondy S. Toluene-induced oxidative stress in several brain regions and other organs. Mol Chem Neuropathol 1993;18:313-328.
24. Chen HH, Lin YR, Chan MH. Toluene exposure during brain growth spurt and adolescence produces differential effects on N-methyl-Daspartate receptor-mediated currents in rat hippocampus. Toxicol Lett 2011;205:336-340.
25. Meyer-Baron M, Blaszkewicz M, Henke H, Knapp G, Muttray A, Schaper M, van Thriel C. The impact of solvent mixtures on neurobehavioral performance: conclusions from epidemiological data. Neurotoxicology 2008;29:349-360.
26. Yucel M, Takagi M, Walterfang M, Lubman D I. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev 2008;32:910-926.
27. Lo PS, Wu CY, Sue HZ, Chen HH. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors. Toxicology 2009;265:34-40.
28. Alfaro-Rodriguez A, Bueno-Nava A, Gonzalez-Pina R, Arch-Tirado E, Vargas-Sanchez J, Avila-Luna A. Chronic exposure to toluene changes the sleep-wake pattern and brain monoamine content in rats. Acta Neurobiol Exp 2011;71:183-192.
29. Lopreato GF, Phelan R, Borghese CM, Beckstead MJ, Mihic SJ. Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend 2003;70:11-15.
30. Cairney S, Maruff P, Burns C, Currie B. The neurobehavioural consequences of petrol (gasoline) sniffing. Neurosci Biobehav Rev 2002;26:81-89.
31. Bowen SE, Balster RL. A direct comparison of inhalant effects on locomotor activity and schedule-controlled behavior in mice. Exp Clin Psychopharmacol 1998;6:235-247.
32. Brouette T, Anton R. Clinical review of inhalants. Am J Addict 2001;10:79-94.
33. Smith A G, Albers J W. n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 1997;20:1445-1450.
34. Spencer PS, Sabri MI, Schaumburg HH, Moore CL. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann Neurol 1979;5:501-507.
35. Gargas ML, Clewell HJ III, Andersen ME. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. Toxicol Appl Pharmacol 1986;82:211-223.
36. Burns MJ, Dickson EW, Sivilotti ML, Hocker M, Porcaro WA. Enhanced mortality from perfluorocarbon administration in a rat model of kerosene aspiration. J Toxicol Clin Toxicol 1999;37:855-859.
37. Schneider S, Schurch D, Geiser M. Aspiration toxicology of hydrocarbons and lamp oils studied by in vitro technology. Toxicol In Vitro 2013;27:1089-1101.
38. Widner LR, Goodwin SR, Berman LS, Banner MJ, Freid EB, McKee TW. Artificial surfactant for therapy in hydrocarbon-induced lung injury in sheep. Crit Care Med 1996;24:1524-1529.
39. Sen V, Kelekci S, Selimoglu Sen H, Yolbas I, Gunes A, Abakay O, Fuat Gurkan M. An evaluation of cases of pneumonia that occurred secondary to hydrocarbon exposure in children. Eur Rev Med Pharmacol Sci 2013;17:9-12.
40. Dice WH, Ward G, Kelley J, Kilpatrick WR. Pulmonary toxicity following gastrointestinal ingestion of kerosene. Ann Emerg Med 1982;11:138-142.
41. Brock WJ, Rusch GM, Trochimowicz HJ. Cardiac sensitization: methodology and interpretation in risk assessment. Regul Toxicol Pharmacol 2003;38:78-90.
42. Muller SP, Wolna P, Wunscher U, Pankow D. Cardiotoxicity of chlorodibromomethane and trichloromethane in rats and isolated rat cardiac myocytes. Arch Toxicol 1997;71:766-777.
43. Himmel HM. Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons? Crit Rev Toxicol 2008;38:773-803.
44. Zhou Y, Wu HJ, Zhang YH, Sun HY, Wong TM, Li GR. Ionic mechanisms underlying cardiac toxicity of the organochloride solvent trichloromethane. Toxicology 2011;290:295-304.
45. Jiao Z, De Jes ú s VR, Iravanian S, Campbell DP, Xu J, Vitali JA, et al. A possible mechanism of halocarbon-induced cardiac sensitization arrhythmias. J Mol Cell Cardiol 2006; 41: 698-705.
46. Sakai K, Maruyama-Maebashi K, Takatsu A, Fukui K, Nagai T, Aoyagi M, et al. Sudden death involving inhalation of 1,1-difluoroethane (HFC-152a) with spray cleaner: Three case reports. Forensic Sci Int 2011;206:e58-e61.
47. Banathy LJ, Chan LT. Fatality caused by inhalation of " l iquid paper" correction fluid. Med J Aust 1983;2:606.
48. Wiseman MN, Banim S. " Glue sniffer ' s " heart? Br Med J (Clin Res Ed) 1987;294:739.
49. Liamis G, Milionis HJ, Elisaf M. Pharmacologically-induced metabolic acidosis: a review. Drug Saf 2010;33:371-391.
50. Carlisle EJ, Donnelly SM, Vasuvattakul S, Kamel KS, Tobe S, Halperin ML. Glue-sniffing and distal renal tubular acidosis: sticking to the facts. J Am Soc Nephrol 1991;1:1019-1027.
51. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 2002;34:83-448.
52. Baskerville J, Tichenor G, Rosen P. Toluene induced hypokalemia: case report and literature review. Emerg Med J 2001;18:514-516.
53. Olgar S, Oktem F, Dindar A, Kilbas A, Turkoglu U D, Cetin H, et al. Volatile solvent abuse caused glomerulopathy and tubulopathy in street children. Hum Exp Toxicol 2008;27:477-483.
54. Batlle DC, Sabatini S, Kurtzman NA. On the mechanism of toluene-induced renal tubular acidosis.[Erratum appears in Nephron 1988;50(1):following 87]. Nephron 1988;49:210-218.
55. Al-Ghamdi SS, Raftery MJ, Yaqoob MM. Acute solvent exposure induced activation of cytochrome P4502E1 causes proximal tubular cell necrosis by oxidative stress. Toxicol In Vitro 2003;17:335-341.
56. Garland EL, Howard MO. Phenomenology of adolescent inhalant intoxication. Exp Clin Psychopharmacol 2010;18:498-509.
57. King MD, Day RE, Oliver JS, Lush M, Watson JM. Solvent encephalopathy. Br Med J (Clin Res Ed) 1981; 283: 663-665.
58. Capron B, Logan BK. Toluene-impaired drivers: behavioral observations, impairment assessment, and toxicological findings. J Forensic Sci 2009;54:486-489.
59. Kubota T, Miyata A. Acute inhalational exposure to chlorodifluoromethane (freon-22): a report of 43 cases. J Toxicol Clin Toxicol 2005;43:305-308.
60. Korman M, Trimboli F, Semler I. A comparative evaluation of 162 inhalant users. Addict Behav 1980;5:143-152.
61. Garland EL, Howard MO. Adverse consequences of acute inhalant intoxication. Exp Clin Psychopharmacol 2011;19:134-144.
62. Reed BJ, May PA. Inhalant abuse and juvenile delinquency: a control study in Albuquerque, New Mexico. Int J Addict 1984;19:789-803.
63. Morrow LA, Steinhauer SR, Condray R, Hodgson M. Neuropsychological performance of journeymen painters under acute solvent exposure and exposure-free conditions. J Int Neuropsychol Soc 1997;3:269-275.
64. Stollery BT. Long-term cognitive sequelae of solvent intoxication. Neurotoxicol Teratol 1996;18:471-476.
65. Shepherd RT. Mechanism of sudden death associated with volatile substance abuse. Hu Toxicol 1989;8:287-291.
66. Ikeda N, Takahashi H, Umetsu K, Suzuki T. The course of respiration and circulation in ' toluene-sniffing '. Forensic Sci Int 1990;44:151-158.
67. El-Menyar AA, El-Tawil M, Al Suwaidi J. A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation. Eur J Emerg Med 2005;12:137-141.
68. van Valen E, Wekking E, van der Laan G, Sprangers M, van Dijk F. The course of chronic solvent induced encephalopathy: a systematic review. Neurotoxicology 2009;30:1172-1186.
69. Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain 1998;121:1903-1917.
70. Rosenberg NL, Spitz MC, Filley CM, Davis KA, Schaumburg HH. Central nervous system effects of chronic toluene abuse-clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988;10:489-495.
71. van Valen E, van Thriel C, Akila R, Nilson LN, Bast-Pettersen R, Sainio M, et al. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics. Neurotoxicology 2012;33:710-726.
72. Dingwall KM, Maruff P, Fredrickson A, Cairney S. Cognitive recovery during and after treatment for volatile solvent abuse. Drug Alcohol Depend 2011;118:180-185.
73. Linz DH, de Garmo PL, Morton WE, Wiens AN, Coull BM, Maricle RA. Organic solvent-induced encephalopathy in industrial painters. J Occup Med 1986;28:119-125.
74. Takagi M, Lubman DI, Cotton S, Fornito A, Baliz Y, Tucker A, Yucel M. Executive control among adolescent inhalant and cannabis users. Drug Alcohol Rev 2011;30:629-637.
75. Wu LT, Howard MO. Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2007;88:146-155.
76. Okada S, Yamanouchi N, Kodama K, Uchida Y, Hirai S, Sakamoto T, et al. Regional cerebral blood flow abnormalities in chronic solvent abusers. Psychiatry Clin Neurosci 1999;53:351-356.
77. Wu LT, Howard MO, Pilowsky DJ. Substance use disorders among inhalant users: results from the National Epidemiologic Survey on alcohol and related conditions. Addict Behav 2008;33:968-973.
78. Wu LT, Howard MO. Is inhalant use a risk factor for heroin and injection drug use among adolescents in the United States? Addict Behav 2007;32:265-281.
79. Fornazzari L, Pollanen MS, Myers V, Wolf A. Solvent abuse-related toluene leukoencephalopathy. J Clin Forensic Med 2003; 10: 93-95.
80. Dingwall KM, Cairney S. Recovery from central nervous system changes following volatile substance misuse. Subst Use Misuse 2011;46:73-83.
81. Cairney S, O ' Connor N, Dingwall KM, Maruff P, Shafiq-Antonacci R, Currie J, Currie BJ. A prospective study of neurocognitive changes 15 years after chronic inhalant abuse. Addiction 2013;108:1107-1114.
82. Bos PM, de Mik G, Bragt PC. Critical review of the toxicity of methyl n-butyl ketone: risk from occupational exposure. Am J Ind Med 1991;20:175-194.
83. Leandri M, Schizzi R, Scielzo C, Favale E. Electrophysiological evidence of trigeminal root damage after trichloroethylene exposure. Muscle Nerve 1995;18:467-468.
84. Cavanagh JB, Buxton PH. Trichloroethylene cranial neuropathy: is it really a toxic neuropathy or does it activate latent herpes virus? J Neurol Neurosurg Psychiatry 1989;52:297-303.
85. Zhang M, Wang Y, Wang Q, Yang D, Zhang J, Wang F, Gu Q. Ethylbenzene-induced hearing loss, neurobehavioral function, and neurotransmitter alterations in petrochemical workers. J Occup Environ Med 2013;55:1001-1006.
86. Patel R, Benjamin J. Renal disease associated with toluene inhalation. J Toxicol Clin Toxicol 1986;24:213-223.
87. Tang HL, Chu KH, Cheuk A, Tsang WK, Chan HW, Tong KL. Renal tubular acidosis and severe hypophosphataemia due to toluene inhalation. Hong Kong Med 2005;11:50-53.
88. Tsao JH, Hu YH, How CK, Chern CH, Hung-Tsang Yen D, Huang CI. Atrioventricular conduction abnormality and hyperchloremic metabolic acidosis in toluene sniffing. J Formos Med Assoc 2011;110:652-654.
89. Streicher HZ, Gabow PA, Moss AH, Kono D, Kaehny WD. Syndromes of toluene sniffing in adults. Ann Intern Med 1981;94:758-762.
90. Chiang WF, Yeh FC, Lin SH. Unilateral paralysis associated with profound hypokalemia. Am J Emerg Med 2012; 30: 2100 e5-7.
91. Voigts A, Kaufman CE Jr. Acidosis and other metabolic abnormalities associated with paint sniffing. South Med J 1983;76:443-447, 452.
92. Marjot R, McLeod AA. Chronic non-neurological toxicity from volatile substance abuse. Hum Toxicol 1989;8:301-306.
93. Bonzel KE, Muller-Wiefel DE, Ruder H, Wingen AM, Waldherr R, Weber M. Anti-glomerular basement membrane antibody-mediated glomerulonephritis due to glue sniffing. Eur J Pediatr 1987;146:296-300.
94. Jolliff HA, Fletcher E, Roberts KJ, Baker SD, McKenzie LB. Pediatric hydrocarbon-related injuries in the United States: 2000-2009. Pediatrics 2013;131:1139-1147.
95. Khanna P, Devgan S C, Arora V K, Shah A. Hydrocarbon pneumonitis following diesel siphonage. Indian J Chest Dis Allied Sci 2004;46:129-132.
96. Neeld EM, Limacher MC. Chemical pneumonitis after the intravenous injection of hydrocarbon. Radiology 1978; 129: 36.
97. Fink K, Kuehnemund A, Schwab T, Geibel-Zehender A, Bley T, Bode C, Busch HJ. Suicide attempt by intravenous injection of gasoline: a case report. J Emerg Med 2010;39:618-622.
98. Gentina T, Tillie-Leblond I, Birolleau S, Saidi F, Saelens T, Boudoux L, et al. Fire-eater ' s lung: seventeen cases and a review of the literature. Medicine (Baltimore) 2001;80:291-297.
99. Lucas GN. Kerosene oil poisoning in children: a hospital-based prospective study in Sri Lanka. Indian J Pediatr 1994;61:683-687.
100. Van Gorcum TF, Hunault CC, Van Zoelen GA, De Vries I, Meulenbelt J. Lamp oil poisoning: did the European guideline reduce the number and severity of intoxications? J Toxicol Clin Toxicol 2009;47:29-34.
101. Lifshitz M, Sofer S, Gorodischer R. Hydrocarbon poisoning in children: a 5-year retrospective study. Wilderness Environ Med 2003;14:78-82.
102. WHO Emro Pediatric Hydrocarbon Study Group CE, Bond GR, Pieche S, Sonicki Z, Gamaluddin H, El Guindi M, Sakr M, et al. A clinical decision rule for triage of children under 5 years of age with hydrocarbon (kerosene) aspiration in developing countries. J Toxicol Clin Toxicol 2008;46:222-229.
103. Khilnani GC, Hadda V. Lipoid pneumonia: an uncommon entity. Indian J Med Sci 2009;63:474-480.
104. Zanetti G, Marchiori E, Gasparetto TD, Escuissato DL, Soares Souza A Jr. Lipoid pneumonia in children following aspiration of mineral oil used in the treatment of constipation: high-resolution CT findings in 17 patients. Pediatr Radiol 2007;37:1135-1139.
105. Betancourt SL, Martinez-Jimenez S, Rossi SE, Truong MT, Carrillo J, Erasmus JJ. Lipoid pneumonia: spectrum of clinical and radiologic manifestations. AJR Am J Roentgenol 2010;194:103-109.
106. Baron SE, Haramati LB, Rivera VT. Radiological and clinical findings in acute and chronic exogenous lipoid pneumonia. J Thorac Imaging 2003;18:217-224.
107. Farahvash M R, Yegane R A, Bashashati M, Ahmadi M, Tabrizi N. Surgical approach to hydrocarbon injection in upper extremities: case series. Int J Surg 2009;7:382-386.
108. Rauber-Luthy C, Kupferschmidt H. Household chemicals: management of intoxication and antidotes. EXS 2010;100:339-363.
109. Monteiro-Riviere NA, Inman AO, Riviere JE. Skin toxicity of jet fuels: ultrastructural studies and the effects of substance P. Toxicol Appl Pharmacol 2004;195:339-347.
110. Mazzeo PA, Renny M, Osterhoudt KC. A toddler with curiosity and a cough. Pediatr Emerg Care 2010;26:232-235.
111. Kahai J, Rotta A, Quadrani D, Alashari M, Joshi P, Steinhorn D. Partial liquid ventilation (PLV) attenuates lung injury in a hydrocarbon aspiration injury (HAI) [abstract]. J Toxicol Clin Toxicol 1998;36:427-428.
112. McDougal JN, Rogers JV. Local and systemic toxicity of JP-8 from cutaneous exposures. Toxicol Lett 2004;149:301-308.
113. Flanagan RJ, Ruprah M, Meredith TJ, Ramsey JD. An introduction to the clinical toxicology of volatile substances. Drug Saf 1990;5:359-383.
114. Kurniali PC, Henry L, Kurl R, Meharg JV. Inhalant abuse of computer cleaner manifested as angioedema. Am J Emerg Med 2012;30:265. e3-5.
115. Phatak D R, Walterscheid J. Huffing air conditioner fluid: a cool way to die? Am J Forensic Med Pathol 2012;33:64-67.
116. Wisler JW, Wisler JR, Coffey R, Miller SF. The diversity of wound presentation associated with freon contact frostbite injury. J Burn Care Res 2010;31:809-812.
117. Plumb J, Thomas RG. Sudden severe perioral swelling in an adolescent boy. J Toxicol Clin Toxicol 2013;51:379-380.
118. Wiper JD, Grant I, Kay SP. Deliberate soft tissue injection of petrol. J Plast Reconstr Aesthet Surg 2011;64:e95-e97.
119. Seymour FK, Henry JA. Assessment and management of acute poisoning by petroleum products. Hum Exp Toxicol 2001;20:551-562.
120. Weber LWD, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003;33:105-136.
121. Thiesen FV, Noto AR, Barros HM. Laboratory diagnosis of toluenebased inhalants abuse. J Toxicol Clin Toxicol 2007;45:557-562.
122. Kaufman JD, Silverstein MA, Moure-Eraso R. Atrial fibrillation and sudden death related to occupational solvent exposure. Am J Ind Med 1994;25:731-735.
123. Taylor GJ, Harris WS. Glue sniffing causes heart block in mice. Science 1970;170:866-868.
124. Aydin K, Sencer S, Demir T, Ogel K, Tunaci A, Minareci O. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 2002;23:1173-1179.
125. Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse, J Toxicol Clin Toxicol 2002;40:21-34.
126. Duncan J R, Dick A L, Egan G, Kolbe S, Gavrilescu M, Wright D, et al. Adolescent toluene inhalation in rats affects white matter maturation with the potential for recovery following abstinence. PLoS One [Electronic Resource] 2012;7:e44790.
127. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, Dreisbach JN, Hormes JT, Filley CM. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988;23:611-614.
128. Yucel M, Zalesky A, Takagi MJ, Bora E, Fornito A, Ditchfield M, et al. White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study, J Psychiatry Neurosci 2010;35:409-412.
129. Mallavarapu RK, Katner HP. Pneumatocele complicating acute hydrocarbon pneumonitis. J Toxicol Clin Toxicol 2008; 46: 911.
130. Schikler KN, Lane EE, Seitz K, Collins WM. Solvent abuse associated pulmonary abnormalities. Adv Alcohol Subst Abuse 1984;3:75-81.
131. Carr F, Prasad B. An unusual case of renal tubular acidosis. BMJ Case Rep 2011;2011.
132. Reddy P. Clinical approach to renal tubular acidosis in adult patients. Int J Clin Pract 2011;65:350-360.
133. Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med 2004;164:1561-1566.
134. Heard K. The changing indications of gastrointestinal decontamination in poisonings. Clin Lab Med 2006;26:1-12, vii.
135. Holstege C, Meekings P. Decontamination of the poisoned patient. In: Roberts JR, Hedges JR, eds. Clinical Procedures in Emergency Medicine, 5th edition. Philadelphia, PA: Elsevier; 2009. pp. 760-772.
136. American Academy of Clinical Toxicology, European Association of Poison Centres, Clinical Toxicologists. Position Paper: Single-Dose Activated Charcoal. J Toxicol Clin Toxicol 2005;43:61-87.
137. Anas N, Namasonthi V, Ginsburg CM. Criteria for hospitalizing children who have ingested products containing hydrocarbons. J Am Med Assoc 1981;246:840-843.
138. Machado B, Cross K, Snodgrass WR. Accidental hydrocarbon ingestion cases telephoned to a regional poison center. Ann Emerg Med 1988;17:804-807.
139. Chyka PA. Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol 1996; 34: 357-363.
140. Horoz OO, Yildizdas D, Yilmaz HL. Surfactant therapy in acute respiratory distress syndrome due to hydrocarbon aspiration. Singapore Med J 2009; 50: e130-e132.
141. Mastropietro CW, Valentine K. Early administration of intratracheal surfactant (calfactant) after hydrocarbon aspiration. Pediatrics 2011;127:e1600-e1604.
142. Fraser J, Mok Q. Severe lung injury following aspiration of scented lamp oil. Intensive Care Med 2001;27:614.
143. Mabe TG, Honeycutt T, Cairns BA, Kocis KC, Short KA. High-frequency percussive ventilation in a pediatric patient with hydrocarbon aspiration. Pediatr Crit Care Med 2007; 8: 383-385.
144. Kopec KT, Brent J, Banner W, Ruha AM, Leikin JB. Management of cardiac dysrhythmias following hydrocarbon abuse: clinical toxicology teaching case from NACCT acute and intensive care symposium. J Toxicol Clin Toxicol 2014;52:141-145.
145. Konghom S, Verachai V, Srisurapanont M, Suwanmajo S, Ranuwattananon A, Kimsongneun N, Uttawichai K. Treatment for inhalant dependence and abuse. Cochrane Database Syst Rev 2010;12:CD007537.
146. MacLean S, Cameron J, Harney A, Lee NK. Psychosocial therapeutic interventions for volatile substance use: a systematic review. Addiction 2012;107:278-288.
147. Ogel K, Coskun S. Cognitive behavioral therapy-based brief intervention for volatile substance misusers during adolescence: a follow-up study. Subst Use Misuse 2011;46:128-133.
148. Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA, Kranzler HR. Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatr Serv 1998;49:812-815.
149. Muralidharan K, Rajkumar RP, Mulla U, Nayak RB, Benegal V. Baclofen in the management of inhalant withdrawal: a case series. Prim Care Companion J Clin Psychiatry 2008;10:48-51.
150. Lee DE, Schiffer WK, Dewey SL. Gamma-vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP). Synapse 2004;54:183-185.